EligibleTrials

Clinical trials recruiting for Gastroesophageal Junction Cancer

5
Recruiting trials
23
US states with sites
19
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 4Phase 2 2

Drugs and treatments being studied

InterventionTrials
5-Fluorouracil1
AZD09011
BL-M07D11
DR-02021
Gemcitabine1
IKS0141
Irinotecan1
Leucovorin1
MCLA-1581
MCLA-158 + FOLFIRI1
MCLA-158 + FOLFOX1
MCLA-158 + Pembrolizumab1

Where trials are recruiting (top US states)

StateRecruiting trials
Texas5
California4
Florida3
Massachusetts3
New York3
Tennessee3
Virginia3
Colorado2
Georgia2
Michigan2
Oklahoma2
Alabama1

Top cities

Boston, Massachusetts 3Houston, Texas 3Nashville, Tennessee 3Orlando, Florida 3Dallas, Texas 2Detroit, Michigan 2Fairfax, Virginia 2Los Angeles, California 2New York, New York 2Oklahoma City, Oklahoma 2

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Gastroesophageal Junction Cancer often also study these conditions. Each links to its own recruiting-trial list.

Gastric cancer 91Breast cancer 2239Urothelial Carcinoma 29Pancreatic Ductal Adenocarcinoma 64Pancreatic cancer 870Ovarian cancer 118Lung cancer 2180Head and Neck Squamous Cell Carcinoma 42Esophageal cancer 65Endometrial cancer 68

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Gastroesophageal Junction Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.